Cita APA (7a ed.)

CJ, L., & YY, T. (2016). Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity. Dove Medical Press.

Cita Chicago Style (17a ed.)

CJ, Lin, y Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.

Cita MLA (8a ed.)

CJ, Lin, y Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.